Peppermint Completes $4.7 Million Seed Round
Start here
AI-assisted source synthesis · not an independent investigation.
On October 8, 2026, Peppermint announced that it had secured $4.7 million in seed funding to expand its AI-powered financial operations platform for clinical research teams. The platform connects to clinical trial management software data and cross-checks it against payment records and trial contracts, continuously issuing invoices and collecting payments to address clinical trial billing issues. Early user data cited in reports indicated that the platform increased revenue recovery speed threefold, reduced overdue invoices threefold, and reduced employee billing time by 20%. Peppermint will also use the new funds for budget negotiations, expense management, and clinical trial analytics.
AI-written from reports · updated 8 days ago
Timeline
Follow the reporting to see the different sides of the story.
- PYMNTSPeppermint raises $4.7 million to tackle clinical trial billing issues
Peppermint has raised $4.7 million in seed funding to expand its AI financial operations platform for clinical research teams and tackle clinical trial billing issues. The platform connects to clinical trial management software data, cross-checks it against payment records and trial contracts, and issues invoices and follows up on payments instantly and continuously. Early users have tripled the speed of revenue collection, reduced overdue invoices threefold, and cut employee billing time by 20%; the new funding will also support budget negotiations, expense management, and clinical trial analytics.